177A Kohjin Bio Co.,Ltd. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

177A

TSE Growth

Kohjin Bio Co.,Ltd.

1,237

JPY

-20

(-1.59%)

Mar 13, 3:30 pm JST

7.76

USD

Mar 13, 2:30 am EDT

Result

PTS

outside of trading hours

ー

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2022 ＊	3,947	969	917	587	173.5	10	ー	J-GAAP
Mar, 2023 ＊	4,742	1,267	1,244	829	199.2	19	ー	J-GAAP
Mar, 2024 ＊	4,770	596	635	384	92.4	14	May 15, 2024	J-GAAP
Mar, 2025	5,206	991	1,065	794	157.6	24	May 14, 2025	J-GAAP
Mar, 2026 Guidance	4,971	464	467	335	65.5	10	Feb 13, 2026	J-GAAP
YoY	-4.5%	-53.2%	-56.2%	-57.8%	-58.4%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2024	Apr 25, 2024	4,724	537	560	289	14	J-GAAP
Results	May 15, 2024	4,770	596	635	384	14	J-GAAP
Mar, 2025	May 15, 2024	Available in future release
Results	May 14, 2025	Available in future release
Mar, 2026	May 14, 2025	5,679	1,065	1,135	822	25	J-GAAP
	Feb 13, 2026	4,971	464	467	335	10	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2019	2,275	－	Available in future release
Mar, 2020	2,825	+24.2
Mar, 2021	3,251	+15.1
Mar, 2022	3,947	+21.4
Mar, 2023	4,742	+20.1
Mar, 2024	4,770	+0.6
Mar, 2025	5,206	+9.1
Mar, 2026 Guidance	4,971	-4.5	464	-53.2	467	-56.2	65.5	-58.4

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2024 ＊	4,770	596	12.5	12.08	6.04	0.75	92.4
Mar, 2025	5,206	991	19.0	17.41	10.14	0.67	157.6
Mar, 2026 Guidance	4,971	464	9.33	5.66	3.74	0.55	65.5

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	5,206	1,267	1,244	829	202.4
Fiscal Year	Mar, 2025	Mar, 2023	Mar, 2023	Mar, 2023	Mar, 2021

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	2,559	590	605	442	106.4	14	May 15, 2024	J-GAAP
Oct - Mar, 2024	2,699	612	649	517	102.6	24	May 14, 2025	J-GAAP
Oct - Mar, 2025 Guidance	2,467	207	195	133	26.0	10	Feb 13, 2026	J-GAAP
YoY	-8.6%	-66.2%	-70.0%	-74.3%	-74.6%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2023	1,267	-114	461	-575	-172	1,462	23.83	J-GAAP
Mar, 2024	596	246	823	-577	-1	1,726	26.20	J-GAAP
Mar, 2025	991	-175	915	-1,090	1,376	2,949	32.53	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2023	3,544	370	397	207	49.7	ー	ー	J-GAAP
Apr - Dec, 2024	3,923	675	740	516	103.0	69.5	Feb 14, 2025	J-GAAP
Apr - Dec, 2025	3,791	387	385	279	54.7	82.4	Feb 13, 2026	J-GAAP
YoY	-3.4%	-42.7%	-48.0%	-45.9%	-46.9%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jan - Mar, 2024	1,226	226	238	177	42.6	18.4	May 15, 2024	J-GAAP
Apr - Jun, 2024	1,241	206	225	162	33.6	16.6	Aug 14, 2024	J-GAAP
Jul - Sep, 2024	1,266	173	191	115	23.1	13.7	Nov 14, 2024	J-GAAP
Oct - Dec, 2024	1,416	296	324	239	47.7	20.9	Feb 14, 2025	J-GAAP
Jan - Mar, 2025	1,283	316	325	278	55.2	24.6	May 14, 2025	J-GAAP
Apr - Jun, 2025	1,219	131	116	82	16.1	10.7	Aug 14, 2025	J-GAAP
Jul - Sep, 2025	1,285	126	156	120	23.5	9.8	Nov 13, 2025	J-GAAP
Oct - Dec, 2025	1,287	130	113	77	15.1	10.1	Feb 13, 2026	J-GAAP
YoY	-9.1%	-56.1%	-65.1%	-67.8%	-68.3%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Apr - Jun, 2023	1,003	－	Available in future release
Jul - Sep, 2023	1,208	－
Oct - Dec, 2023	1,333	－
Jan - Mar, 2024	1,226	－
Apr - Jun, 2024	1,241	+23.7
Jul - Sep, 2024	1,266	+4.8
Oct - Dec, 2024	1,416	+6.2
Jan - Mar, 2025	1,283	+4.6
Apr - Jun, 2025	1,219	-1.8
Jul - Sep, 2025	1,285	+1.5
Oct - Dec, 2025	1,287	-9.1	130	-56.1	113	-65.1	15.1	-68.3

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	1,416	364	367	278	63.7
Fiscal Year	Dec, 2024	Dec, 2023	Dec, 2023	Mar, 2025	Dec, 2023

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2023	724.57	49.2	6,134	3,017	2,222	0.70	ー	J-GAAP
Mar, 2024	802.50	50.7	6,589	3,342	2,528	0.74	May 15, 2024	J-GAAP
Mar, 2025	1,131.12	63.8	9,066	5,781	3,265	0.35	May 14, 2025	J-GAAP
Apr - Dec, 2025	ー	66.0	8,958	5,916	3,422	0.32	Feb 13, 2026	J-GAAP

Kohjin Bio Co.,Ltd.(177A) Financial Results